Schweizer Clarifies Kerry's Insider Trading

Peter Schweizer talks about John Kerry's claims that his investments are kept at arms length.

In July 2009, pharmaceutical industry representatives met with key members of Congress to flesh out the Obamacare bill. Then, in November 2009, with the bill’s passage was looking more likely, the Kerrys’ portfolios reflect a drug stock buying spree...